Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.23.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2023
SIGNIFICANT ACCOUNTING POLICIES  
Schedule of calculation of weighted average dilutive common shares

    

For the Three Months Ended

March 31, 

    

2023

    

2022

Warrants [1]

4,980,963

5,122,074

Restricted stock units

531,095

855,989

Restricted stock awards

52,087

307,491

Stock options

 

36,667

 

94,447

 

5,600,812

 

6,380,001

[1]  Includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share.